全文获取类型
收费全文 | 22722篇 |
免费 | 1128篇 |
国内免费 | 168篇 |
专业分类
耳鼻咽喉 | 269篇 |
儿科学 | 412篇 |
妇产科学 | 341篇 |
基础医学 | 3382篇 |
口腔科学 | 368篇 |
临床医学 | 2104篇 |
内科学 | 4305篇 |
皮肤病学 | 732篇 |
神经病学 | 2784篇 |
特种医学 | 1228篇 |
外科学 | 2815篇 |
综合类 | 155篇 |
一般理论 | 7篇 |
预防医学 | 1063篇 |
眼科学 | 512篇 |
药学 | 1809篇 |
中国医学 | 28篇 |
肿瘤学 | 1704篇 |
出版年
2023年 | 100篇 |
2022年 | 159篇 |
2021年 | 289篇 |
2020年 | 242篇 |
2019年 | 296篇 |
2018年 | 387篇 |
2017年 | 311篇 |
2016年 | 439篇 |
2015年 | 482篇 |
2014年 | 688篇 |
2013年 | 854篇 |
2012年 | 1341篇 |
2011年 | 1411篇 |
2010年 | 804篇 |
2009年 | 818篇 |
2008年 | 1465篇 |
2007年 | 1521篇 |
2006年 | 1593篇 |
2005年 | 1608篇 |
2004年 | 1476篇 |
2003年 | 1502篇 |
2002年 | 1418篇 |
2001年 | 307篇 |
2000年 | 243篇 |
1999年 | 328篇 |
1998年 | 333篇 |
1997年 | 276篇 |
1996年 | 221篇 |
1995年 | 181篇 |
1994年 | 206篇 |
1993年 | 151篇 |
1992年 | 117篇 |
1991年 | 136篇 |
1990年 | 121篇 |
1989年 | 105篇 |
1988年 | 109篇 |
1987年 | 77篇 |
1986年 | 86篇 |
1985年 | 85篇 |
1984年 | 96篇 |
1983年 | 86篇 |
1982年 | 85篇 |
1981年 | 98篇 |
1980年 | 72篇 |
1979年 | 69篇 |
1978年 | 53篇 |
1977年 | 70篇 |
1976年 | 73篇 |
1974年 | 64篇 |
1955年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder 总被引:1,自引:0,他引:1
Thürmann PA Steffen J Zwernemann C Aebischer CP Cohn W Wendt G Schalch W 《European journal of nutrition》2002,41(5):228-235
Summary. Background: Bioavailability of β-carotene is highly variable and depends on the source, the formulation and other nutritional factors.
Objective: It was the aim of the study to compare β-carotene plasma response to b-carotene dosing with two commercially available drinks,
containing β-carotene from carrot juice or as water dispersible β-carotene powder. Design In a randomized, parallel group
study design, 4 volunteers per group received daily β-carotene doses of 6–7 or 18–22 mg of either drink over 6 weeks. Blood
samples for determination of carotenoid and vitamin A plasma concentrations were collected before supplementation and over
the dosing period. Results: Apparent steady-state β-carotene concentrations were attained after 40 days of supplementation. Consumption of the beverage
containing β-carotene as a water dispersible powder resulted in a higher response of β-carotene plasma concentrations with
increments of 3.84 ± 0.60 μmol/L (p < 0.05, dose: 7.2 mg/d) and 5.04 ± 0.72 μmol/L (p < 0.05, dose: 21.6 mg/d), respectively,
in comparison to the carrot juice-based drink with increments of 0.42 ± 0.33 μmol/L (dose: 6 mg/d) and 1.71 ± 0.55 μmol/L
(dose: 18 mg/d), respectively. β-carotene was cleared from the plasma with an apparent half-life of 6–11 days. Plasma concentrations
of α-carotene, β-cryptoxanthin, lutein, zeaxanthin, and lycopene remained almost unchanged, whereas retinol plasma concentrations
increased slightly. By contrast, with the exception of elevated 13-cis-retinoic acid in one group (21.6 mg/d, water dispersible
powder), the concentrations of all-trans-retinoic acid, and the oxo-derivatives or retinoic acid were not significantly affected
by b-carotene supplementation. Conclusions: The results confirm that the relative bioavailability of β-carotene depends largely on the source of b-carotene and demonstrate
the superior bioavailability of β-carotene powder in comparison to that in carrot juice.
Received: 7 May 2002, Accepted: 22 August 2002
This work was supported by a grant from F. Hoffmann-La Roche Ltd., Vitamins and Nutrition Research, Basle, Switzerland.
Correspondence to: Prof. Dr. med. Petra A. Thürmann 相似文献
992.
Aerosolized perfluorocarbon reduces adhesion molecule gene expression and neutrophil sequestration in acute respiratory distress 总被引:4,自引:0,他引:4
Schoof E von der Hardt K Kandler MA Abendroth F Papadopoulos T Rascher W Dötsch J 《European journal of pharmacology》2002,457(2-3):195-200
In acute respiratory distress syndrome, neutrophil migration into the lung plays a key role in the development of lung injury. To study the effect of different modes of ventilation with perfluorocarbon (FC77), intrapulmonary neutrophil accumulation and mRNA expression of E-selectin, P-selectin and intercellular adhesion molecule-1 (ICAM-1), mediating leukocyte sequestration, were measured in surfactant depleted piglets. After bronchoalveolar lavage, 20 animals either received aerosolized perfluorocarbon (Aerosol-PFC), partial liquid ventilation (PLV) with perfluorocarbon at functional residual capacity filling volume (FRC-PLV) or at low volume (LV-PLV) or intermittent mandatory ventilation (control). After 2 h of perfluorocarbon application, intermittent mandatory ventilation was continued for 6 h. In the Aerosol-PFC group, all measured adhesion molecules showed a significantly reduced gene expression compared to controls. FRC-PFC treatment was effective in significantly diminishing P-selectin and ICAM-1 mRNA expression. Relative lung tissue neutrophil counts were significantly reduced in the Aerosol-PFC and the FRC-PLV group. Treatment with aerosolized perfluorocarbon is at least as effective as partial liquid ventilation at FRC volume in reducing pulmonary adhesion molecule expression and neutrophil accumulation in acute respiratory distress syndrome. 相似文献
993.
Matter H Kotsonis P Klingler O Strobel H Fröhlich LG Frey A Pfleiderer W Schmidt HH 《Journal of medicinal chemistry》2002,45(14):2923-2941
The family of homodimeric nitric oxide synthases (NOS I-III) catalyzes the generation of the cellular messenger nitric oxide (NO) by oxidation of the substrate L-arginine. The rational design of specific NOS inhibitors is of therapeutic interest in regulating pathological NO levels associated with sepsis, inflammatory, and neurodegenerative diseases. The cofactor (6R)-5,6,7,8-tetrahydrobiopterin (H(4)Bip) maximally activates all NOSs and stabilizes enzyme quaternary structure by promoting and stabilizing dimerization. Here, we describe the synthesis and three-dimensional (3D) quantitative structure-activity relationship (QSAR) analysis of 65 novel 4-amino- and 4-oxo-pteridines (antipterins) as inhibitors targeting the H(4)Bip binding site of the neuronal NOS isoform (NOS-I). The experimental binding modes for two inhibitors complexed with the related endothelial NO synthase (NOS-III) reveal requirements of biological affinity and form the basis for ligand alignment. Different alignment rules were derived by building other compounds accordingly using manual superposition or a genetic algorithm for flexible superposition. Those alignments led to 3D-QSAR models (comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA)), which were validated using leave-one-out cross-validation, multiple analyses with two and five randomly chosen cross-validation groups, perturbation of biological activities by randomization or progressive scrambling, and external prediction. An iterative realignment procedure based on rigid field fit was used to improve the consistency of the resulting partial least squares models. This led to consistent and highly predictive 3D-QSAR models with good correlation coefficients for both CoMFA and CoMSIA, which correspond to experimentally determined NOS-II and -III H(4)Bip binding site topologies as well as to the NOS-I homology model binding site in terms of steric, electrostatic, and hydrophobic complementarity. These models provide clear guidelines and accurate activity predictions for novel NOS-I inhibitors. 相似文献
994.
To provide local gentamicin delivery for 1 week based on a biodegradable system, poly(lactic-co-glycolic acid) (PLGA) microparticles were developed utilizing a 50/50 blend of Resomer RG 502H, an uncapped variety of 13.5 kD, and Resomer RG 503, an endcapped polymer of 36.2 kD. The liberation mechanism was investigated by analysis of morphological changes and thermal analysis focusing on the polymer glass transition temperature (T(g)) and the mechanical properties. The release of gentamicin was related to a structural breakdown of the particles reaching a critical molecular weight. A T(g) of < 37 degrees C in the hydrated state was not indicative of collapse and agglomeration of the particles because the mechanical strength of the polymer structures in the rubbery state may still render sufficient support. As the gap between incubation temperature and T(g) widened, the mechanical stability of the PLGA microparticles decreased and became decisive. Particles prepared with RG 502H show a lower ability to bear mechanical stress than RG 503 and 50/50 RG 502H/RG 503 microparticles. 相似文献
995.
Lang PM Tracey DJ Irnich D Sippel W Grafe P 《Naunyn-Schmiedeberg's archives of pharmacology》2002,366(5):449-457
Receptors for ATP in the peripheral nervous system may contribute to the transduction of sensory, including nociceptive, stimuli and are candidates in the pathogenesis of neuropathic pain. In a complex neural tissue, such as the human peripheral nerve trunk, ATP may activate P2X, P2Y, and adenosine receptors present on various cell types. Experiments were performed on segments of isolated human sural nerves. The experimental set-up enabled simultaneous recording of C fiber excitability, intracellular Ca(2+) ([Ca(2+)](i)) and extracellular K(+) activity (aK(e)). The increase in excitability of unmyelinated fibers seen during bath application of both ATP and adenosine was reversed to a reduction in axonal excitability in the presence of 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolol[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385), an antagonist of adenosine A2 receptors. The pharmacological profile of the axonal subexcitability indicates the presence and activation of adenosine A1 receptors. Intracellular Ca(2+) transients were observed during bath application of ATP but not of adenosine and were blocked by 2'-deoxy- N(6)-methyladenosine 3',5'-bisphosphate (MRS 2179), an antagonist at P2Y(1) receptors. K(+)-sensitive microelectrodes were used to search for a possible activation of P2X receptors by ATP. In isolated rat vagus nerve, activation of P2X receptors by alpha,beta-methylene-adenosine 5'-triphosphate (alpha,beta-meATP) and by diadenosine pentaphosphate (Ap5A) resulted in a rapid, transient rise in the extracellular K(+) activity. In contrast, in human nerve, application of P2X receptor agonists did not result in a detectable elevation of aK(e). The data suggest that ATP-induced changes in axonal excitability and of [Ca(2+)](i) result from activation of adenosine A2, A1 and P2Y nucleotide receptors in human nerve; a contribution of P2X receptors was not found with the methods used. It is suggested that antagonists of A2 receptors might suppress enhanced activity in human nociceptive afferent nerve fibers under conditions in which ATP and/or adenosine is released into the trunk of a human peripheral nerve. 相似文献
996.
Metabolism and kinetics of bisphenol a in humans at low doses following oral administration 总被引:12,自引:0,他引:12
Völkel W Colnot T Csanády GA Filser JG Dekant W 《Chemical research in toxicology》2002,15(10):1281-1287
997.
There has been tremendous progress in the immunomodulatory treatment of multiple sclerosis (MS) during recent years. With the introduction of interferon-beta, glatiramer acetate and mitoxantrone (recently registered for MS in the US), there are at least three therapeutic strategies that have proven effective in large phase III studies. However, not all patients with MS respond well to treatment with these drugs. This may largely be a consequence of disease heterogeneity. From a clinical perspective, patients with different disease courses show different treatment responses. Patients with relapsing-remitting MS are more likely to respond to immunomodulatory therapy than those with a progressive disease course. Studies of patients with secondary progressive MS have yielded inconsistent results and, so far, there has been no positive phase III study of immunomodulatory therapy in patients with primary progressive MS. Pathological evidence indicates that subtyping based on clinical findings alone does not reflect actual disease heterogeneity. In a large series of biopsy and autopsy specimens, at least four subtypes could be identified with respect to oligodendrocyte/myelin pathology and immunopathology. As long as the only method of identifying subtypes of disease is histopathology, differential therapy will remain a future goal. Thus, there is an urgent need for in vivo markers of immunopathogenesis in an individual patient that would allow treatment to be specifically directed towards a given pathological focus. However, at least from a theoretical point of view, some therapeutic approaches appear very attractive. Plasmapheresis and/or intravenous immunoglobulins could most plausibly be the best approach for the immunopathological subtype of MS, which is characterised by antibody and complement deposition next to demyelinated axons, in order to remove antibodies. The subtype of MS that is associated with heavy macrophage activation, T cell infiltration and expression of inflammatory mediator molecules, including tumour necrosis factor-alpha, may be most likely to respond to immunomodulation with interferon-beta or glatiramer acetate. There are other subtypes of MS in which viral infection or oligodendrocyte degeneration, rather than autoimmunity, appear to play a role. It is possible that these could benefit from antiviral therapy, oligodendrocyte protection or oligodendrocyte transplantation, although therapies based on these latter approaches have yet to be developed. 相似文献
998.
999.
1000.